Loading clinical trials...
Loading clinical trials...
This study will be undertaken to determine whether the frequency of fetal surveillance can be safely reduced from bi-weekly to weekly in the case of fetusus with intrauterine growth restriction.
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Bezmialem Vakif University
NCT05500989 · Pre-Eclampsia, HELLP Syndrome, and more
NCT05038462 · Fetal Growth Retardation, Intrauterine Growth Restriction
NCT03398629 · Intrauterine Growth Restriction, Fetal Anomaly, and more
NCT07483424 · Intrauterine Growth Restriction (IUGR)
NCT02583763 · IUGR, Fetal Growth Retardation, and more
Bezmialem Vakıf University Hospital
Istanbul
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions